{
  "zip": "6000",
  "sector": "Healthcare",
  "longBusinessSummary": "Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline. It has a strategic partnership with CannPal Pty Ltd; and St Vincent's Hospital on opioid reduction study. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited is based in Perth, Australia.",
  "city": "Perth",
  "phone": "61 8 6558 0886",
  "state": "WA",
  "country": "Australia",
  "companyOfficers": [],
  "website": "http://www.zeliratx.com",
  "maxAge": 1,
  "address1": "140 St George's Terrace",
  "fax": "61 8 6316 3337",
  "industry": "Biotechnology",
  "address2": "Level 26",
  "previousClose": 0.079,
  "regularMarketOpen": 0.0895,
  "twoHundredDayAverage": 0.052502286,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0895,
  "navPrice": null,
  "averageDailyVolume10Day": 80676,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.079,
  "fiftyDayAverage": 0.06898606,
  "trailingAnnualDividendRate": null,
  "open": 0.0895,
  "averageVolume10days": 80676,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.188524,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.06796,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 44506,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 87422800,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 112452,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.06796,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 44506,
  "fiftyTwoWeekHigh": 0.09,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0179,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0895,
  "exchange": "PNK",
  "shortName": "ZELIRA THERAPEUTICS LTD",
  "longName": "Zelira Therapeutics Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ZLDAF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_318884570",
  "uuid": "ead3e738-90ec-3865-b219-5670c021ee7e",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 1185319936,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.006,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1593475200,
  "heldPercentInstitutions": 0.04618,
  "netIncomeToCommon": null,
  "trailingEps": -0.002,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 12.666666,
  "heldPercentInsiders": 0.28601998,
  "nextFiscalYearEnd": 1656547200,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 804477737,
  "enterpriseValue": 90240592,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0895,
  "logo_url": "https://logo.clearbit.com/zeliratx.com"
}